Market revenue in 2023 | USD 2,324.5 million |
Market revenue in 2030 | USD 7,398.9 million |
Growth rate | 18% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Infectious Diseases |
Historical data covered | 2021 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Infectious Diseases |
Key market players worldwide | Moderna Inc, BioNTech SE ADR, CureVac NV Ordinary Shares, Arcturus Therapeutics Holdings Inc, Sanofi SA, GSK PLC, Pfizer Inc, AstraZeneca PLC, Argos Therapeutics, ETHRIS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific mrna therapeutics market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
The mRNA therapeutics market in the Asia Pacific (APAC) is propelled by increasing investment in biotechnology, advancements in healthcare infrastructure, and a growing focus on precision medicine. Drivers include significant government initiatives in countries like China and Japan, fostering collaborations with mRNA technology developers.
Future trends involve expanding applications beyond infectious diseases to oncology and genetic disorders, with notable examples being China’s investment in mRNA research and Japan’s efforts in personalized medicine.
Partnerships between local pharmaceutical companies and global leaders exemplify the region’s potential. As APAC addresses challenges related to healthcare access and regulatory frameworks, the mRNA therapeutics market is poised for substantial growth, offering innovative solutions for diverse medical conditions.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific mrna therapeutics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific mrna therapeutics market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account